microdosing glp 1 for inflammation GLP-1 and Gut Health: Addressing Metabolic Dysfunction Physicians GLP-1 Microdosing, Brain Health &

Long-Term Health Implications Long-term use of Rybelsus and Januvia offers distinct health benefits for managing type 2 diabetes

Programs that offer subscription-based medication services often cost upwards of $300 per month, and these non-FDA approved compounded GLP-1 medications raise serious concerns due to variability in dosage, potential for harmful additives, and lack of rigorous safety and efficacy testing

These drugs are both dopamine and cholinergic receptor antagonists that act on the area postrema in the brainstem

IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target

While preclinical studies have provided important mechanistic insights into the CV effects of GLP-1RAs, many experimental models of atherosclerosis, MI, or heart failure were conducted in mice that, despite being fed an HFD or HCD, do not develop the severe obesity or T2D that characterize patients treated with GLP-1RAs in CVOTs